Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
- Written by PR Newswire Asia - News Pronto RSS
 |
- After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation in Australia's BreastScreen NSW Machine Reading Solution Project
SEOUL, South Korea, Dec. 11, 2023/PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its progression to the second stage...
Read more: Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project